Active Filter(s):
Details:
The partnership aims to jointly develop emodepside, an anthelmintic substance that is effective against several gastrointestinal nematodes in domestic animals, in the clinical development for treating humans infected with soil-transmitted helminths.
Lead Product(s): Emodepside
Therapeutic Area: Infections and Infectious Diseases Product Name: BAY 44-4400
Highest Development Status: Phase II Product Type: Peptide
Partner/Sponsor/Collaborator: Swiss TPH
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership July 20, 2023